Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neuroone Medical Technologies (NMTC) Leases (2020 - 2026)

Neuroone Medical Technologies filings provide 7 years of Leases readings, the most recent being $196775.0 for Q1 2026.

  • On a quarterly basis, Leases fell 36.86% to $196775.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $196775.0, a 36.86% decrease, with the full-year FY2025 number at $255195.0, changed 0.11% from a year prior.
  • Leases hit $196775.0 in Q1 2026 for Neuroone Medical Technologies, down from $226251.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $339271.0 in Q4 2024 to a low of $110724.0 in Q1 2024.
  • Median Leases over the past 5 years was $226251.0 (2025), compared with a mean of $227662.5.
  • Biggest five-year swings in Leases: crashed 50.79% in 2024 and later soared 181.47% in 2025.
  • Neuroone Medical Technologies' Leases stood at $252119.0 in 2022, then plummeted by 44.39% to $140198.0 in 2023, then surged by 141.99% to $339271.0 in 2024, then plummeted by 33.31% to $226251.0 in 2025, then fell by 13.03% to $196775.0 in 2026.
  • The last three reported values for Leases were $196775.0 (Q1 2026), $226251.0 (Q4 2025), and $255195.0 (Q3 2025) per Business Quant data.